Polygonatum cyrtonema polysaccharide and its preparation method and application
Polysaccharide prepared by ultrasonic extraction and decomposition of impurities has solved the research gap in the regulation of polysaccharide on intestinal microbiota, and achieved bacterial flora correction and colony richness adjustment under immunosuppression conditions, demonstrating its Potential application as a modulator of intestinal microbiota.
Patent Information
- Application Number
- CN202111515444.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-12-13
- Publication Date
- 2024-11-01
- Estimated Expiration
- 2041-12-13
AI Technical Summary
The prior art has failed to effectively study and utilize Polygonatum to regulate the intestinal flora, especially in the correction of flora disorders and colony richness adjustment under immunosuppressive conditions.
Polysaccharide polysaccharide was prepared by ultrasonic water extraction and decomposition method, and an immunosuppressive mouse model was established by injection of cyclophosphamide, and the drug was administered in gavage, and the intestinal microbiota of mice was detected, and the colony abundance and community diversity were adjusted. sex.
Polysaccharide polysaccharide can adjust the colony abundance of intestinal flora in mice, correct the disorder of intestinal flora under immunosuppression, increase the abundance of Lactobacillus and Lachnospiraceae_NK4A136 population, reduce the abundance of Parabacteroides colonies, and show that it is used as an intestinal Potential applications of tractobacterial modulators.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
Technical Field
[0001] The invention belongs to the field of natural plant extracts, and specifically relates to a polygonatum cyrtonema polysaccharide and a preparation method and application thereof. Background Art
[0002] Polygonatum cyrtonema, also known as chicken-head ginseng and tiger ginger, is the dried rhizome of Polygonatum cyrtonema Hua., a plant of the genus Polygonatum Mill. of the Liliaceae family. It is included in the 2015 edition of the Chinese Pharmacopoeia (Part I) together with the dried rhizomes of Polygonatum Kingianum Coll. et Hemsl. and Polygonatum sibiricum Red. It has the effects of replenishing qi and nourishing yin, strengthening the spleen, moistening the lungs, and benefiting the kidneys. It is a plant that is both a medicine and a food. It is mainly distributed in the Yangtze River Basin, Guangdong, Guangxi and other places in my country. Polygonatum cyrtonema polysaccharide is the main pharmacologically active ingredient of Polygonatum cyrtonema, which has the effects of lowering blood sugar and blood lipids, anti-tumor, antibacterial, anti-inflammatory, antiviral, immunomodulatory, antioxidant, and liver and kidney protection. Literature search has not found any related research reports on the effect of Polygonatum cyrtonema polysaccharide on intestinal flora. The changes in the composition and structure of intestinal flora are related to the body's immune function, such as obesity, insulin resistance, autoimmune diseases, inflammatory bowel disease, autism, cardiovascular and cerebrovascular diseases, tumors, etc. Therefore, the study of the regulatory activity of Polygonatum sibiricum polysaccharide on intestinal flora is of great significance. Summary of the invention
[0003] The present invention provides a Polygonatum cyrtonema polysaccharide having the function of regulating intestinal flora, characterized in that the preparation method of the Polygonatum cyrtonema polysaccharide comprises the following steps:
[0004] (1) taking dried rhizomes of Polygonatum cyrtonema, crushing them, adding water for ultrasonic extraction, collecting the extract, and concentrating it to obtain a crude extract;
[0005] (2) adding an appropriate amount of water to the crude extract, dissolving by ultrasonication, fixing the volume, adding 8-10 times the volume of anhydrous ethanol, standing at 0-4°C, centrifuging, discarding the supernatant, collecting the precipitate, washing the precipitate with ethanol, and freeze-drying to obtain crude polysaccharide;
[0006] (3) The crude polysaccharide is prepared into a crude polysaccharide solution with a mass concentration of 1.0 g / L, a mixed solution of chloroform-n-butanol (volume ratio 4:1) is added, the solution is shaken, allowed to stand and then centrifuged, the middle protein layer and the lower organic layer are discarded, the operation is repeated 1-3 times until no obvious white precipitate appears, 8-10 times the volume of anhydrous ethanol is added to the water layer, allowed to stand at 0-4°C and then centrifuged, the supernatant is discarded, the precipitate is collected, the precipitate is washed with ethanol, and freeze-dried to obtain the polygonatum polysaccharide.
[0007] The amount of water used in step (1) is 6-10 times the amount of the rhizome of Polygonatum cyrtonema, the ultrasonic extraction temperature is preferably 80-90°C, the number of extractions is preferably 2-5 times, the ultrasonic frequency is 30-40kHz, each ultrasonic extraction is 0.5-1.0h, and the water is selected from distilled water or deionized water. The pulverization is preferably pulverized to 20-100 mesh.
[0008] The amount of water used in step (2) is preferably 0.6-1.0 times the weight of the rhizome of Polygonatum cyrtonema, the ultrasonic frequency is 30-40kHz, the standing time is preferably 8-10h, and the centrifugal speed is preferably 3000r·min -1 , the preferred time is 3-5min.
[0009] In step (3), the amount of the chloroform-n-butanol mixed solution is preferably 20%-25% of the volume of the crude polysaccharide solution; the standing time is preferably 3-5 hours, and the centrifugal speed is preferably 3000 r·min -1 , the preferred time is 3-5min.
[0010] The ethanol used to wash the precipitate in steps (2) and (3) is preferably an ethanol solution with a volume fraction of 90%-95%.
[0011] Another embodiment of the present invention provides the use of the above-mentioned Polygonatum cyrtonema polysaccharide in adjusting the colony richness of intestinal flora and correcting the disorder of intestinal flora caused by immunosuppression.
[0012] Another embodiment of the present invention provides the use of the above-mentioned Polygonatum cyrtonema polysaccharide in adjusting the diversity of intestinal flora in mice under immunosuppression.
[0013] Another embodiment of the present invention provides the use of the above-mentioned Polygonatum cyrtonema polysaccharide in reducing the abundance of Parabacteroides colonies in intestinal flora.
[0014] Another embodiment of the present invention provides the use of the above-mentioned Polygonatum cyrtonema polysaccharide in increasing the abundance of Lactobacillus; and / or increasing the abundance of F_lachnospiraceae_unclassified and Lachnospiraceae_NK4A136_group colonies in the intestinal flora.
[0015] Another embodiment of the present invention provides the use of the above-mentioned Polygonatum cyrtonema polysaccharide in the preparation of an intestinal flora regulator.
[0016] An intestinal flora regulator, characterized in that the above-mentioned Polygonatum cyrtonema polysaccharide is used as an effective ingredient. It may also include other intestinal flora regulators. It may also include pharmaceutically acceptable excipients, and its dosage form is selected from solid preparations, liquid preparations, etc. Its dosage is preferably 200-600 mg / kg, more preferably 400-600 mg / kg, and more preferably 400, 600 mg / kg.
[0017] Compared with the prior art, the advantages of the present invention are: the present invention obtains the pure active Polygonatum cyrtonema polysaccharide through ultrasonic water extraction and alcohol precipitation to remove impurities, and establishes an immunosuppressive mouse model by injection of cyclophosphamide, and administers Polygonatum cyrtonema polysaccharide by gavage, and through detecting relevant indicators of the intestinal flora of mice, it is found that Polygonatum cyrtonema polysaccharide can adjust the colony abundance of the intestinal flora of mice, correct the disorder of the intestinal flora of immunosuppressed mice, and has a regulating effect on the intestinal flora of immunosuppressed mice, and is expected to be developed as an intestinal flora regulator. BRIEF DESCRIPTION OF THE DRAWINGS
[0018] Figure 1 It is the OTU abundance clustering heat map.
[0019] Figure 2 It is an OTU Venn diagram or petal diagram.
[0020] Figure 3 It is a species distribution histogram.
[0021] Figure 4 is the PCA plot.
[0022] Figure 5 This is a comparison chart of the differences in bacterial species abundance. DETAILED DESCRIPTION
[0023] 1. Experimental Materials
[0024] 1.1 Experimental materials and animals
[0025] Polygonatum cyrtonema Hua. was purchased in Xilin County, Baise, Guangxi in 2019 and identified as Polygonatum cyrtonema Hua. by Researcher Tan Xiaoming of Guangxi University of Chinese Medicine. The samples were preserved in the Scientific Experimental Center of Guangxi University of Chinese Medicine. Male mice (weight 20±2g) were purchased from Hunan Slake Jingda Experimental Animal Co., Ltd.
[0026] 1.2 Main experimental instruments and reagents
[0027] Electronic balance (PL203, Mettler-Toledo Instrument (Shanghai) Co., Ltd.; T500, Changshu Shuangjie Testing Instrument Factory), high-speed multifunctional pulverizer (WJX-100, Shanghai Yuanwo Industry and Trade Co., Ltd.), digital display constant temperature water bath (HH-6, Changzhou Guohua Electric Co., Ltd.), desktop centrifuge (Centrifuge5810R, Aibende China Co., Ltd.), ultrasonic cleaning machine (SB-800DTD, Ningbo Xinzhi Biotechnology Co., Ltd.), freeze dryer (Alpha 2-4LSCbasic, CHRIST Company) Cyclophosphamide for injection (8I261A, Baxter International Co., Ltd.), 0.9% sodium chloride injection (Echo Bi Group Jiangxi East Asia Pharmaceutical Co., Ltd.), PBS phosphate buffer (NA, Fuzhou Maixin), Lysing Buffer (8304565, BD).
[0028] 2. Experimental Methods
[0029] 2.1 Preparation of Polygonatum cyrtonema polysaccharide
[0030] (1) Accurately weigh 500 g of dried rhizome of Polygonatum cyrtonema, crush it, pass it through a 20-mesh sieve, add 4000 mL of distilled water, and extract it three times with ultrasonic wave (40 kHz) at 90°C, each time for 1.0 h. Collect the extract and concentrate it to obtain a crude extract.
[0031] (2) Add an appropriate amount of water (300 mL) to the crude extract obtained in step (1), dissolve it by ultrasonication (40 kHz), adjust the volume (to 500 mL), add 4000 mL of anhydrous ethanol, let it stand at 0-4°C for 8 h, and centrifuge (3000 r / min) -1 , 3min), discard the supernatant, collect the precipitate, wash the precipitate with 95% by volume ethanol, and freeze-dry to obtain 80.5g of crude polysaccharide.
[0032] (3) Take an appropriate amount of crude polysaccharide to prepare a crude polysaccharide solution (1.0 L) with a mass concentration of 1.0 g / L, add a mixed solution (200 mL) of chloroform-n-butanol (volume ratio 4:1), shake vigorously, let stand for 4 h, and then centrifuge (3000 r·min -1 , 3min), discard the middle protein layer and the lower organic layer, repeat the operation 1-3 times until no obvious white precipitate appears, add 8-10 times the volume of anhydrous ethanol to the aqueous layer, let it stand at 0-4℃ for 8h and then centrifuge (3000r·min -1 , 3min), discard the supernatant, collect the precipitate, wash the precipitate with 90% by volume ethanol, and freeze-dry to obtain 69.0g of the polygonatum polysaccharide.
[0033] 2.2 Drug preparation
[0034] Preparation of 60mg / kg cyclophosphamide: Take 0.2g cyclophosphamide and add 30mL distilled water to dissolve.
[0035] Preparation of 200mg / kg Polygonatum cyrtonema polysaccharide: dissolve 200mg Polygonatum cyrtonema polysaccharide in 10mL distilled water.
[0036] Preparation of 400mg / kg Polygonatum cyrtonema polysaccharide: dissolve 400mg Polygonatum cyrtonema polysaccharide in 10mL distilled water.
[0037] Preparation of 600mg / kg Polygonatum cyrtonema polysaccharide: dissolve 600mg Polygonatum cyrtonema polysaccharide in 10mL distilled water.
[0038] 2.3 Mouse grouping, modeling and drug administration
[0039] Male mice weighing 18-22g were selected. After 6 days of adaptive feeding, they were randomly divided into 5 groups, 5 mice in each group, namely the normal group (CK), the model group (MG), the low-dose group of Polygonatum cyrtonema (200mg / kg, GH200), the medium-dose group of Polygonatum cyrtonema (400mg / kg, GH400), and the high-dose group of Polygonatum cyrtonema (600mg / kg, GH600). The drug group was given by gavage once a day (according to the weight of mice 1g: 0.01mL), and the control group and the model group were given the same amount of normal saline (according to the weight of mice 1g: 0.01mL), and the drug was given for 7 consecutive days. Except for the normal group, cyclophosphamide 0.2mL (according to the weight of mice 1g: 0.1mL) was injected intraperitoneally at 60mg / kg on the second, fourth and sixth days of feeding to induce immunosuppression in mice. All groups had normal diet and drinking water.
[0040] 2.4 Biological sample collection and indicator determination
[0041] 2.4.1 Feces collection
[0042] On the seventh day after continuous administration, the feces of the mice were collected and stored in a -80°C refrigerator for biological sample processing.
[0043] 2.4.2 Determination of intestinal flora (16S MetaVx TM Method)
[0044] (1) DNA extraction / QC
[0045] DNA was extracted from the samples using a DNA extraction kit. dsDNA HS Assay Kit was used to detect DNA concentration.
[0046] (2) PCR amplification and library construction
[0047] Using 20-30ng DNA as template, a series of PCR primers designed by GeneWeichi were used to amplify two highly variable regions including V3 and V4 on the 16S rDNA of prokaryotes. The upstream primer containing the sequence "CCTACGGRRBGCASCAGKVRVGAAT" and the downstream primer containing the sequence "GGACTACNVGGGTWTCTAATCC" were used to amplify the V3 and V4 regions. In addition, a linker with an index was added to the end of the PCR product of 16SrDNA by PCR for NGS sequencing. The amplification conditions are shown in Table 1:
[0048] Table 1 Amplification conditions
[0049]
[0050] PCR reaction parameters: pre-denaturation parameter 94°C 3min×1, denaturation parameter 94°C 5sec, annealing parameter 57°C 90sec, extension parameter 72°C 10s, final extension parameter 72°C 5min, for a total of 24 cycles.
[0051] Identification of PCR amplification results: PCR products were detected by 1.5% agarose gel electrophoresis.
[0052] (3) Sequencing
[0053] The library concentration was detected by an ELISA reader. The library was quantified to 10 nM, and PE250 / PE300 double-end sequencing was performed according to the instruction manual of the Illumina MiSeq (Illumina, San Diego, CA, USA), and the sequence information was read by the MiSeq Control Software (MCS) provided with the MiSeq.
[0054] 2.5 Data processing
[0055] Graphpad Prism 6.05 software was used to analyze the experimental data, and all data were expressed as Mean ± SEM. The data were expressed as mean ± standard deviation, and t-test and one-way analysis of variance were performed. P < 0.05 was considered statistically significant.
[0056] The species taxonomy analysis of representative sequences of OTU was performed using the RDP classifier (Ribosomal Database Program) Bayesian algorithm, and the community composition of each sample was statistically analyzed at different species classification levels. (un)weighted unifrac analysis was used to compare whether there were significant differences in microbial communities between samples.
[0057] 3 Results of mouse intestinal flora detection
[0058] 3.1 Analysis of the composition of mouse intestinal flora
[0059] According to the results of OTU (Operational Taxonomic Units, OTU) cluster analysis, Figure 1 , a petal diagram was drawn to intuitively display the similarity and overlap of the number of sample OTUs. The results showed that CK, MG, GH200, GH400, and GH600 had a total of 180 species, 2 species were unique to CK, 16 species were unique to MG, 1 species was unique to GH200, 1 species was unique to GH400, and 6 species were unique to GH600, such as Figure 2 shown.
[0060] At the genus level, the species composition of the intestinal flora of each group of mice was slightly different, but the relative abundance of different species varied greatly. Among them, the dominant bacterial communities of CK were mainly f__Lachnospiraceae_Unclassified and Lachnospiraceae_NK4A136_group; the dominant bacterial communities of MG were mainly Alloprevotella, Parabacteroides and Alistipes; the dominant bacterial communities of GH200 were mainly Alloprevotella, f__Lachnospiraceae_Unclassified and Lachnospiraceae_NK4A136_group; the dominant bacterial communities of GH400 were mainly Alloprevotella, f__Lachnospiraceae_Unclassified, Lactobacillus and Prevotellaceae_UCG-001; the dominant bacterial communities of GH600 were mainly Alloprevotella, f__Lachnospiraceae_Unclassified and Parabacteroides.
[0061] The relative abundance of Alloprevotella in GH400 and GH600 was significantly higher than that in CK, MG and GH200. The relative abundance of Lactobacillus in GH400 was significantly higher than that in other groups. Figure 3 .
[0062] 3.2 PCA analysis
[0063] PCA analysis (Principal Component Analysis) of the test results shows that in the two dimensions of PC1 and PC2, all samples of GH400 and GH600 are significantly clustered, CK, MG and GH200 are relatively close, and are relatively far from GH400 and GH600, but the difference is not big; in the two dimensions of PC1 and PC3, the samples of CK, MG, GH200, GH400 and GH600 are basically clustered together, and some samples of CK and GH200 are far away. In the two dimensions of PC2 and PC3, all samples of each experimental group are significantly clustered. The results are as follows: Figure 4 .
[0064] 3.3 Analysis of the significance of community structure differences among groups
[0065] A representative sequence was selected for each OTU to obtain the species classification information corresponding to the OTU. The representative sequences of species classification were annotated using the RDP classifier to obtain the community composition of each sample. Figure 5 Shown are the percentages of the six major bacterial communities at the genus level for each sample. Compared with the normal group, CTX increased the abundance of F_muribaculaceae_unclassified, Bacteroides, and Alalloprevotella in the model group, and decreased the abundance of F_lachnospiraceae_unclassified, Lachnospiraceae_NK4A136_group, and Lactobacillus in the model group. After polysaccharide administration, the abundance of F_muribaculaceae_unclassified, Bacteroides, and Alalloprevotella decreased. The richness of F_lachnospiraceae_unclassified, Lachnospiraceae_NK4A136_group, and Lactobacillus increased significantly.
[0066] 4. Conclusion
[0067] The experimental results showed that Polygonatum cyrtonema polysaccharide can adjust the diversity and structural composition of the intestinal flora of immunosuppressed mice, increase the richness of Lactobacillus, increase the richness of f__Lachnospiraceae_Unclassified, Lachnospiraceae_NK4A136_group colonies, reduce the richness of Parabacteroides colonies, adjust the colony richness of the intestinal flora of mice, and correct the disorder of the intestinal flora of immunosuppressed mice. The results of this experiment showed that Polygonatum cyrtonema polysaccharide has a certain regulatory effect on the disorder of the intestinal flora of immunosuppressed mice, and can be used as a related functional product or additive such as an intestinal flora regulator or an immunomodulator.
Claims
1. A Polygonatum cyrtonema polysaccharide having the function of regulating intestinal flora, characterized in that The preparation method of Polygonatum cyrtonema polysaccharide comprises the following steps: (1) Take the dried rhizome of Polygonatum cyrtonema, crush it, add water to perform ultrasonic extraction, collect the extract, and concentrate it to obtain a crude extract; (2) Add an appropriate amount of water to the crude extract, dissolve it by ultrasonication, make it constant, add 8-10 times the volume of anhydrous ethanol, let it stand at 0-4°C, centrifuge it, discard the supernatant, collect the precipitate, wash the precipitate with ethanol, and freeze-dry it to obtain crude polysaccharide; (3) The crude polysaccharide is prepared into a crude polysaccharide solution with a mass concentration of 1.0 g / L, a chloroform-n-butanol mixed solution with a volume ratio of 4:1 is added, the solution is shaken, allowed to stand and then centrifuged, the middle protein layer and the lower organic layer are discarded, the operation is repeated 1-3 times until no obvious white precipitate appears, 8-10 times the volume of anhydrous ethanol is added to the water layer, allowed to stand at 0-4°C and then centrifuged, the supernatant is discarded, the precipitate is collected, the precipitate is washed with ethanol, and freeze-dried to obtain the polygonatum polysaccharide; In step (1), the amount of water used is 6-10 times the weight of the rhizome of Polygonatum cyrtonema, the ultrasonic extraction temperature is 80-90°C, the number of extractions is 2-5 times, the ultrasonic frequency is 30-40kHz, each ultrasonic extraction is 0.5-1.0 h, and the pulverization is pulverized into 20-100 meshes; In step (2), the amount of water used is 0.6-1.0 times the weight of the rhizome of Polygonatum cyrtonema, the ultrasonic frequency is 30-40kHz, the standing time is 8-10h, and the centrifugal speed is 3000 r·min -1 , time is 3-5 min; In step (3), the amount of chloroform-n-butanol mixed solution is 20%-25% of the volume of the crude polysaccharide solution; the standing time is 3-5 hours, and the centrifugal speed is 3000 r·min -1 , time is 3-5 min; The effect of regulating the intestinal flora is selected from reducing the abundance of Parabacteroides colonies in the intestinal flora, increasing the abundance of Lactobacillus, and / or increasing the abundance of F_lachnospiraceae_unclassified and Lachnospiraceae NK4A136 colonies in the intestinal flora.
2. The method for preparing Polygonatum cyrtonema polysaccharide according to claim 1, characterized in that The steps include: (1) Take the dried rhizome of Polygonatum cyrtonema, crush it, add water to perform ultrasonic extraction, collect the extract, and concentrate it to obtain a crude extract; (2) Add an appropriate amount of water to the crude extract, dissolve it by ultrasonication, make it constant, add 8-10 times the volume of anhydrous ethanol, let it stand at 0-4°C, centrifuge it, discard the supernatant, collect the precipitate, wash the precipitate with ethanol, and freeze-dry it to obtain crude polysaccharide; (3) The crude polysaccharide is prepared into a crude polysaccharide solution with a mass concentration of 1.0 g / L, a chloroform-n-butanol mixed solution with a volume ratio of 4:1 is added, the solution is shaken, allowed to stand and then centrifuged, the middle protein layer and the lower organic layer are discarded, the operation is repeated 1-3 times until no obvious white precipitate appears, 8-10 times the volume of anhydrous ethanol is added to the water layer, allowed to stand at 0-4°C and then centrifuged, the supernatant is discarded, the precipitate is collected, the precipitate is washed with ethanol, and freeze-dried to obtain the polygonatum polysaccharide; In step (1), the amount of water used is 6-10 times the weight of the rhizome of Polygonatum cyrtonema, the ultrasonic extraction temperature is 80-90°C, the number of extractions is 2-5 times, the ultrasonic frequency is 30-40kHz, each ultrasonic extraction is 0.5-1.0 h, and the pulverization is pulverized into 20-100 meshes; In step (2), the amount of water used is 0.6-1.0 times the weight of the rhizome of Polygonatum cyrtonema, the ultrasonic frequency is 30-40kHz, the standing time is 8-10h, and the centrifugal speed is 3000 r·min -1 , time is 3-5 min; In step (3), the amount of chloroform-n-butanol mixed solution is 20%-25% of the volume of the crude polysaccharide solution; the standing time is 3-5 hours, and the centrifugal speed is 3000 r·min -1 , time is 3-5 min.
3. The use of the Polygonatum cyrtonema polysaccharide according to claim 1 in regulating the colony richness of intestinal flora and correcting the disorder of immunosuppressive intestinal flora, characterized in that The effect of regulating the intestinal flora is selected from reducing the abundance of Parabacteroides colonies in the intestinal flora, increasing the abundance of Lactobacillus, and / or increasing the abundance of F_lachnospiraceae_unclassified and Lachnospiraceae NK4A136 colonies in the intestinal flora.
4. Use of the Polygonatum cyrtonema polysaccharide according to claim 1 in the preparation of an intestinal flora regulator.
5. An intestinal flora regulator, characterized in that The Polygonatum cyrtonema polysaccharide described in claim 1 is used as an effective ingredient.
6. The intestinal flora regulator according to claim 5, characterized in that Other intestinal flora modulators are also included.
7. The intestinal flora regulator according to any one of claims 5 to 6, characterized in that It also includes pharmaceutically acceptable excipients, and its dosage form is selected from solid preparations and liquid preparations.
8. The intestinal flora regulator according to claim 7, characterized in that The dosage is 200-600 mg / kg.
